{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:02:47Z","timestamp":1787504567676,"version":"build-2736575974"},"reference-count":28,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education and King Abdulaziz University, DSR, Jeddah, Saudi Arabia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Most surveillance studies in Saudi Arabia have been single-centered or did not use the gold standard broth microdilution (BMD) antimicrobial susceptibility test. This is the first study from Saudi Arabia to evaluate the resistance profiles of Acinetobacter baumannii by using BMD on a national level. Between November 2022 and April 2023, isolates from several infection sites were collected from seven hospitals in seven regions of Saudi Arabia. On testing days, BMD was done following Clinical Laboratory Standards Institute standards. Antibiotic susceptibility percentages and MIC50 and MIC90 were calculated. One hundred A. baumannii isolates were included. The highest susceptibility was to tigecycline (39%) and aminoglycosides (22\u201325%). The MIC90 of all antibiotics were higher than the resistance breakpoint. All isolates (100%) were multidrug-resistant, of which 52% were classified as extensive-drug-resistant, and 42% were identified as pandrug-resistant. The isolates collected from the ear, peritoneal fluid, and the cerebrospinal fluid were all XDR, while 2\/3 of the urine isolates (10\/15; 66.7%), more than 1\/2 of the skin\/soft tissue and respiratory isolates (9\/16; 56.3% and 22\/43; 51.7%, respectively), and 3\/8 (37.5%) of the blood isolates met this definition. Conversely, PDR isolates made up 5\/8 of blood isolates (62.5%), 8\/15 of body fluid isolates (57.14%), and 19\/43 (44.2%) of respiratory isolates. A. baumannii showed a surprisingly high resistance to multiple commonly used antibiotics. Infection control policies and antimicrobial stewardship should be implemented by hospitals throughout the country to improve treatment, track resistance trends with local antibiograms, and prevent the development of resistant strains.<\/jats:p>","DOI":"10.3390\/antibiotics14020209","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T03:29:53Z","timestamp":1739935793000},"page":"209","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A National Surveillance of the Antibiotic Susceptibility of Acinetobacter baumannii in Saudi Arabia"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-9094","authenticated-orcid":false,"given":"Abrar K.","family":"Thabit","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feras S.","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3970-845X","authenticated-orcid":false,"given":"Anas F.","family":"Jawah","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar M.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musaab Y.","family":"Miaji","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Alturki","sequence":"additional","affiliation":[{"name":"Microbiology Department, King Fahad Hospital of the University, Khobar 34445, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"Hosin","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Medicine, Imam Abdulrahman bin Faisal University, Dammam 34212, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0865-8563","authenticated-orcid":false,"given":"Mohammed","family":"Bazuqamah","sequence":"additional","affiliation":[{"name":"Microbiology Department, King Khaled Hospital, Najran 66262, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6531-4877","authenticated-orcid":false,"given":"Masaad Saeed","family":"Almutairi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamad","family":"Alhamed","sequence":"additional","affiliation":[{"name":"Laboratory and Blood Bank Department, King Fahad Specialist Hospital, Qassim 52366, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Elhendawy","sequence":"additional","affiliation":[{"name":"Microbiology Department, King Fahad Hospital, Albaha 65732, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0082-1177","authenticated-orcid":false,"given":"Dalya","family":"Atallah","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, King Abdulaziz University Hospital, Jeddah 22254, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz A.","family":"Humadi","sequence":"additional","affiliation":[{"name":"Laboratory and Blood Bank Department, King Fahad Specialist Hospital, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A.","family":"Alfifi","sequence":"additional","affiliation":[{"name":"Microbiology Department, King Fahad Specialist Hospital, Tabuk 47717, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Alfadel","sequence":"additional","affiliation":[{"name":"Microbiology Department, Maternity and Children Hospital, King Salman Medical City, Madinah 42319, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-8637","authenticated-orcid":false,"given":"Khalid","family":"Eljaaly","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/14656566.2015.993381","article-title":"Antimicrobial resistance: Impact on clinical and economic outcomes and the need for new antimicrobials","volume":"16","author":"Thabit","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2147\/IDR.S166750","article-title":"Insight into Acinetobacter baumannii: Pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities","volume":"11","author":"Asif","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref_3","unstructured":"Clinical and Laboratory Standards Institute (2023). Performance Standards for Antimicrobial Susceptibility Testing: Thertieth Informational Supplement [Document M100-S33], National Committee for Clinical Laboratory Standards."},{"key":"ref_4","unstructured":"World Health Organization (2025, February 11). WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240093461."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Thabit, A.K., Alabbasi, A.Y., Alnezary, F.S., and Almasoudi, I.A. (2023). An Overview of Antimicrobial Resistance in Saudi Arabia (2013\u20132023) and the Need for National Surveillance. Microorganisms, 11.","DOI":"10.3390\/microorganisms11082086"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e01934-17","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_7","unstructured":"Clinical and Laboratory Standards Institute (2025). Performance Standards for Antimicrobial Susceptibility Testing: Thertieth Informational Supplement [Document M100-S35], National Committee for Clinical Laboratory Standards."},{"key":"ref_8","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2025, February 11). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 13.0. Available online: http:\/\/www.eucast.org."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1089\/mdr.2019.0018","article-title":"Antimicrobial susceptibility and molecular characterization of clinical strains of Acinetobacter baumannii in Western Saudi Arabia","volume":"25","author":"Shah","year":"2019","journal-title":"Microb. Drug Resist."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","unstructured":"Product Information: TYGACIL\u00ae (2020). Tigecycline Intravenous Injection. Pfizer, Inc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/2543-1854.259469","article-title":"Acinetobacter baumannii in Saudi Arabia: The New Growing Threat","volume":"3","author":"Kharaba","year":"2019","journal-title":"Saudi Crit. Care J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1007\/s00253-015-6439-y","article-title":"Acinetobacter species as model microorganisms in environmental microbiology: Current state and perspectives","volume":"99","author":"Jung","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cavallo, I., Oliva, A., Pages, R., Sivori, F., Truglio, M., Fabrizio, G., Pasqua, M., Pimpinelli, F., and Di Domenico, E.G. (2023). Acinetobacter baumannii in the critically ill: Complex infections get complicated. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1196774"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/viru.19700","article-title":"Acinetobacter baumannii: An emerging opportunistic pathogen","volume":"3","author":"Howard","year":"2012","journal-title":"Virulence"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","article-title":"International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacotherapy"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.2147\/IDR.S219130","article-title":"Plastic binding feature of polymyxins: The effect on MIC susceptibility measurements","volume":"12","author":"Sharafi","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sutherland, C.A., and Nicolau, D.P. (2014). To add or not to add polysorbate 80: Impact on colistin MICs for clinical strains of Enterobacteriaceae and Pseudomonas aeruginosa and quality controls. J. Clin. Microbiol., 52.","DOI":"10.1128\/JCM.01454-14"},{"key":"ref_19","first-page":"898","article-title":"A surveillance study on the prevalence and antimicrobial resistance pattern among different groups of bacteria isolated from Western province of Saudi Arabia","volume":"28","author":"Alam","year":"2017","journal-title":"Biomed. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00284-019-01836-z","article-title":"Molecular surveillance of multidrug-resistant Acinetobacter baumannii","volume":"77","author":"AlAmri","year":"2020","journal-title":"Curr. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Said, K.B., Alsolami, A., Khalifa, A.M., Khalil, N.A., Moursi, S., Osman, A., Fahad, D., Rakha, E., Rashidi, M., and Moussa, S. (2021). A multi-point surveillance for antimicrobial resistance profiles among clinical isolates of Gram-negative bacteria recovered from major Ha\u2019il hospitals, Saudi Arabia. Microorganisms, 9.","DOI":"10.3390\/microorganisms9102024"},{"key":"ref_22","first-page":"1221","article-title":"Extended-spectrum beta-lactamase and carbapenem-resistant Gram-negative pathogens in Makkah, Saudi Arabia","volume":"32","author":"Kabrah","year":"2022","journal-title":"Ethiop. J. Health Sci."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Saleem, M., Syed Khaja, A.S., Hossain, A., Alenazi, F., Said, K.B., Moursi, S.A., Almalaq, H.A., Mohamed, H., and Rakha, E. (2022). Molecular characterization and antibiogram of Acinetobacter baumannii clinical isolates recovered from the patients with ventilator-associated pneumonia. Healthcare, 10.","DOI":"10.3390\/healthcare10112210"},{"key":"ref_24","first-page":"24","article-title":"A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii","volume":"15","author":"Marie","year":"2015","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e70066","DOI":"10.1002\/hsr2.70066","article-title":"An overview of sulbactam-durlobactam approval and implications in advancing therapeutics for hospital-acquired and ventilator-associated pneumonia by Acinetobacter baumannii-calcoaceticus complex: A narrative review","volume":"7","author":"Anand","year":"2024","journal-title":"Health Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e0078122","DOI":"10.1128\/aac.00781-22","article-title":"In Vitro Activity of Sulbactam-Durlobactam against Global Isolates of Acinetobacter baumannii-calcoaceticus Complex Collected from 2016 to 2021","volume":"66","author":"Karlowsky","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1099\/jmm.0.001211","article-title":"In vitro synergistic activity of the sulbactam\/avibactam combination against extensively drug-resistant Acinetobacter baumannii","volume":"69","author":"Rodriguez","year":"2020","journal-title":"J. Med. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Pasteran, F., Cedano, J., Baez, M., Albornoz, E., Rapoport, M., Osteria, J., Montana, S., Le, C., Ra, G., and Bonomo, R.A. (2021). A New Twist: The Combination of Sulbactam\/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant Acinetobacter baumannii (CRAB) Isolates. Antibiotics, 10.","DOI":"10.3390\/antibiotics10050577"}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/2\/209\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:37:23Z","timestamp":1760027843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/2\/209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["antibiotics14020209"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics14020209","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]}}}